Insider Trading Summary for Eyepoint Pharmaceuticals, Inc. (EYPT): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Apr-24 5:27 PM View:	30-Mar-24 Payment of Exercise ($528.04K)	Paggiarino Dario A. Chief Medical Officer		Eyepoint Pharmaceuticals, Inc. - EYPT	161% 25.71K to 67.08K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 5:38 PM View:	09-Feb-24 Payment of Exercise ($105.29K)	Jones David Scott SVP & Chief Commercial Officer		Eyepoint Pharmaceuticals, Inc. - EYPT	67% 26.82K to 44.92K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 5:38 PM View:	09-Feb-24 Payment of Exercise ($91.93K)	Elston George Chief Financial Officer		Eyepoint Pharmaceuticals, Inc. - EYPT	75% 24.93K to 43.61K	0	0	--	--	Show Txns Hide Txns

16-Jan-24 6:01 PM View:	11-Jan-24 Private Sale Duplicate ($37.16M)	Liu Ye Director		Eyepoint Pharmaceuticals, Inc. - EYPT	(97%) 3.01M to 100.22K	0	0	--	--	Show Txns Hide Txns

09-Jan-24 9:11 PM View:	06-Jan-24 Payment of Exercise ($121.71K)	Pine Michael Craig Chief Corp Dev.&Strat. Officer		Eyepoint Pharmaceuticals, Inc. - EYPT	156% 5.34K to 13.66K	0	0	--	--	Show Txns Hide Txns

26-Jun-23 5:10 PM View:	23-Jun-23 Option Exercise 0	Adamis Anthony P Director		Eyepoint Pharmaceuticals, Inc. - EYPT	100% 0 to 2.0K	0	0	--	--	Show Txns Hide Txns

12-Jul-23 6:51 PM View:	11-Jul-23 Option Exercise 0	Zaderej Karen L. Director		Eyepoint Pharmaceuticals, Inc. - EYPT	100% 0 to 2.0K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 5:40 PM View:	13-Feb-24 Gift 0	Lurker Nancy Executive Vice Chair Director		Eyepoint Pharmaceuticals, Inc. - EYPT	10% 190.56K to 210.24K	0	0	--	--	Show Txns Hide Txns

28-Feb-24 4:46 PM View:	27-Feb-24 Gift 0	Duker Jay S. President and CEO Director		Eyepoint Pharmaceuticals, Inc. - EYPT	78% 29.22K to 51.92K	0	0	--	--	Show Txns Hide Txns

06-Sep-23 5:14 PM View:	01-Sep-23 Sale ($197.98K)	Essex Woodlands Fund Ix, L.P. 10% Owner		Eyepoint Pharmaceuticals, Inc. - EYPT	(17%) 4.19M to 3.49M	0	($6.61M) (12%)	--	$10.92 - $14.62	Show Txns Hide Txns

22-Apr-24 4:00 PM View:	18-Apr-24 Purchase $10.49M	Cormorant Asset Management,... 10% Owner		Eyepoint Pharmaceuticals, Inc. - EYPT	112% 3.53M to 7.47M	0	0	--	--	Show Txns Hide Txns

16-Jan-24 6:55 PM View:	11-Jan-24 Private Sale ($37.16M)	Ocumension Therapeutics Director		Eyepoint Pharmaceuticals, Inc. - EYPT	(97%) 3.01M to 100.22K	0	0	--	--	Show Txns Hide Txns

Eyepoint Pharmaceuticals, Inc. (EYPT)

Last Year

28-Apr-23 -- 27-Apr-24

Company Sentiment

Scientific & Technical Instruments

Electronics

Two Year Chart

28-Apr-22 -- 27-Apr-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades